WallStSmart

JPMorgan Chase & Co (JPM)vsNakamoto Inc. (NAKA)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

JPMorgan Chase & Co generates 671488% more annual revenue ($190.73B vs $28.40M). JPM leads profitability with a 34.6% profit margin vs 0.0%. NAKA trades at a lower P/E of 3.8x. JPM earns a higher WallStSmart Score of 71/100 (B).

JPM

Strong Buy

71

out of 100

Grade: B

Growth: 7.3Profit: 8.0Value: 5.7Quality: 3.0
Piotroski: 4/9Altman Z: 0.55

NAKA

Hold

37

out of 100

Grade: F

Growth: 5.3Profit: 2.5Value: 6.7Quality: 4.0
Piotroski: 2/9Altman Z: 1.12

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

JPM5 strengths · Avg: 9.2/10
Market CapQuality
$902.16B10/10

Mega-cap, among the largest globally

Profit MarginProfitability
34.6%10/10

Keeps 35 of every $100 in revenue as profit

Operating MarginProfitability
42.6%10/10

Strong operational efficiency at 42.6%

P/E RatioValuation
14.3x8/10

Attractively priced relative to earnings

Price/BookValuation
2.6x8/10

Reasonable price relative to book value

NAKA3 strengths · Avg: 10.0/10
P/E RatioValuation
3.8x10/10

Attractively priced relative to earnings

Price/BookValuation
0.5x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
8680.0%10/10

Revenue surging 8680.0% year-over-year

Areas to Watch

JPM3 concerns · Avg: 2.3/10
PEG RatioValuation
1.574/10

Expensive relative to growth rate

Altman Z-ScoreHealth
0.552/10

Distress zone — elevated risk

Debt/EquityHealth
3.321/10

Elevated debt levels

NAKA4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$127.59M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : JPM

The strongest argument for JPM centers on Market Cap, Profit Margin, Operating Margin. Profitability is solid with margins at 34.6% and operating margin at 42.6%. Revenue growth of 10.2% demonstrates continued momentum.

Bull Case : NAKA

The strongest argument for NAKA centers on P/E Ratio, Price/Book, Revenue Growth. Revenue growth of 8680.0% demonstrates continued momentum.

Bear Case : JPM

The primary concerns for JPM are PEG Ratio, Altman Z-Score, Debt/Equity. Debt-to-equity of 3.32 is elevated, increasing financial risk.

Bear Case : NAKA

The primary concerns for NAKA are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

JPM profiles as a mature stock while NAKA is a hypergrowth play — different risk/reward profiles.

NAKA carries more volatility with a beta of 15.70 — expect wider price swings.

NAKA is growing revenue faster at 8680.0% — sustainability is the question.

Monitor BANKS - DIVERSIFIED industry trends, competitive dynamics, and regulatory changes.

Bottom Line

JPM scores higher overall (71/100 vs 37/100), backed by strong 34.6% margins and 10.2% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

JPMorgan Chase & Co

FINANCIAL SERVICES · BANKS - DIVERSIFIED · USA

JPMorgan Chase & Co. is an American multinational investment bank and financial services holding company headquartered in New York City. JPMorgan Chase is incorporated in Delaware. As a Bulge Bracket bank, it is a major provider of various investment banking and financial services. It is one of America's Big Four banks, along with Bank of America, Citigroup, and Wells Fargo. JPMorgan Chase is considered to be a universal bank and a custodian bank. The J.P. Morgan brand is used by the investment banking, asset management, private banking, private wealth management, and treasury services divisions.

Visit Website →

Nakamoto Inc.

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company is headquartered in Salt Lake City, Utah.

Visit Website →

Want to dig deeper into these stocks?